Clinical Trials in Tennessee

Showing 15141-15160 of 17,345 trials

Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

NCT00301990

RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Bevacizumab may also stop the growth of tumor cells by blocking blood flow to the tumor. Interleukin-2 may stimulate the white blood cells to kill tumor cells. Giving bevacizumab together with interleukin-2 may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving bevacizumab together with interleukin-2 works in treating patients with metastatic kidney cancer.

Kidney Cancer

Jonsson Comprehensive Cancer Center65 participantsStarted Sep 2005

Los Angeles, California, United States • Maywood, Illinois, United States • Indianapolis, Indiana, United States +8 more locations

UNKNOWNPhase 329 miles

Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

NCT00008281

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which regimen of chemotherapy is more effective for metastatic colorectal cancer. PURPOSE: Phase III trial to compare the effectiveness of three chemotherapy regimens in treating patients who have metastatic colorectal cancer.

Colorectal Cancer

SanofiStarted Oct 2000

Huntsville, Alabama, United States • Mobile, Alabama, United States • Tucson, Arizona, United States +131 more locations

Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Find Trials by Condition in Tennessee

A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea

DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension

Tiotropium In Exercise

Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis

A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth

Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer

A Study of the Safety and Efficacy of Fabrazyme (Agalsidase Beta) as Compared to Placebo in Patients With Advanced Fabry Disease

Exploratory Study of Pagoclone in Men With Premature Ejaculation.

Study to Evaluate the Prospective Payment System

Dose Finding Study of Gadavist in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection

Feasibility Study to Determine the Effects of Phrenic Nerve Stimulation in Patients With Periodic Breathing

Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Youth Partners in Care: Depression and Quality Improvement

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

SciBase International Melanoma Pivotal Study

A Comparison of Air Insufflation, Water Immersion and Water Exchange Colonoscopy in CRC Screening